Literature DB >> 12058216

Lethal hemorrhage caused by aortoenteric fistula following endovascular stent implantation.

Volker Kahlke1, Joachim Brossmann, Hans-Jürgen Klomp.   

Abstract

A 55-year-old women developed an aortointestinal fistula between the bifurcation of the aorta and the distal ileum following implantation of multiple endovascular stents into both common iliac arteries for treatment of aortoiliac occlusive disease. Ten months before the acute onset of the gastrointestinal hemorrhage two balloon-expandable steel stents had been implanted into both common iliac arteries. Due to restenosis and recurrent intermittent claudication, three balloon-expandable covered stents were implanted 4 months later on reintervention. The patient presented with abdominal pain and melena, and fell into hemorrhagic shock with signs of upper gastrointestinal bleeding. After transfer to our hospital, she again developed hemorrhagic shock with massive upper and lower gastrointestinal bleeding and died during emergency laparotomy. The development of aortoenteric fistulas following endovascular surgery/stent implantation is very rare and has to be considered in cases of acute gastrointestinal hemorrhage.

Entities:  

Mesh:

Year:  2002        PMID: 12058216     DOI: 10.1007/s00270-001-0086-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Arterio-enteric Fistula - An Unusual Complication of Improper Wound Closure.

Authors:  Atul Gupta; G L Tiwari
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Intracranial arteriovenous fistula caused by endovascular stent-grafting and dilatation.

Authors:  M O Möllers; W Reith
Journal:  Neuroradiology       Date:  2004-03-09       Impact factor: 2.804

3.  [Recurrent upper gastrointestinal bleeding in a 61 year-old man with infrarenal abdominal aortic aneurysm].

Authors:  M Brueck; D Bandorski; K Rauber; J Bindewald; R Jakobs
Journal:  Internist (Berl)       Date:  2008-10       Impact factor: 0.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.